Kezar Life Sciences Inc [KZR] stock prices are up 52.52% to $6.36 at the moment. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The KZR shares have gain 50.71% over the last week, with a monthly amount glided 69.15%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Kezar Life Sciences Inc [NASDAQ: KZR] stock has seen the most recent analyst activity on October 17, 2025, when William Blair downgraded its rating to a Mkt Perform. Previously, Jefferies downgraded its rating to Hold on October 17, 2025, and kept the price target unchanged to $7. On August 11, 2023, downgrade downgraded it’s rating to Equal Weight but maintained its price target of $4 on the stock. William Blair downgraded its rating to a Mkt Perform. Wells Fargo initiated its recommendation with a Overweight and recommended $19 as its price target on December 08, 2021. In a note dated July 16, 2018, Wells Fargo initiated an Outperform rating and provided a target price of $30 on this stock.
The stock price of Kezar Life Sciences Inc [KZR] has been fluctuating between $3.53 and $8.60 over the past year. Currently, Wall Street analysts expect the stock to reach $6 within the next 12 months. Kezar Life Sciences Inc [NASDAQ: KZR] shares were valued at $6.36 at the most recent close of the market. An investor can expect a potential drop of -5.66% based on the average KZR price forecast.
Analyzing the KZR fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.65, Equity is -0.64 and Total Capital is -0.8. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.1.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 5.86 points at the first support level, and at 5.36 for the second support level. However, for the 1st resistance point, the stock is sitting at 6.63, and for the 2nd resistance point, it is at 6.90.
Ratios To Look Out For
It’s worth pointing out that Kezar Life Sciences Inc [NASDAQ:KZR]’s Current Ratio is 7.29. As well, the Quick Ratio is 7.29, while the Cash Ratio is 2.39.
Transactions by insiders
Recent insider trading involved Chiang Pichi Luo, SVP, Corporate Controller, that happened on Jul 02 ’25 when 264.0 shares were sold. Chief Operating Officer, Schiller Mark C. completed a deal on Jul 02 ’25 to sell 561.0 shares.
